Veness Adam M

SEC CIK: 0001778623

SEC filings (opens in a new tab)

In the past year, 2 open-market sale filings worth $4.63M and no purchases.

Current role at each company

DNTH Dianthus Therapeutics, Inc.SVP, General Counsel and Sec.as of Aug 14, 2026
CYT Cyteir Therapeutics, Inc.General Counselas of Feb 7, 2023
XLRN Acceleron Pharma IncSVP, General Counsel and Sec.as of Nov 22, 2021

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: $4.63M; 2 filings
Net: −$4.63M; Bought minus sold
Companies: 1; With open-market trades

Trades

Every Form 4 that lists Veness Adam M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

DNTH Dianthus Therapeutics, Inc.

SVP, General Counsel and Sec.2 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Aug 11, 2026 (view filing)5:08 PM ET	Aug 7-10	4 days	Veness Adam MSVP, General Counsel and Sec.	SSale	−20.0K	$110.44	−$2.21M	−100.0%0 after	3 lots10b5-1
Jun 18, 2026 (view filing)	Jun 17	1 day	Veness Adam MSVP, General Counsel and Sec.	SSale	−30.0K	$80.80	−$2.42M	−100.0%0 after	2 lots10b5-1

XLRN Acceleron Pharma Inc